Panavance Therapeutics to Participate in the Virtual Investor Summer Spotlight Series

Panavance Therapeutics

BERWYN, PAPanavance Therapeutics Inc., a clinical-stage pharmaceutical company, announced that Greg Bosch, Chairman and CEOJames Costin, M.D., Head of Research & DevelopmentJosé Iglesias, M.D., Chief Medical Officer, and Ben Steinmetz, Chief Commercial Officer of Panavance Therapeutics will participate in the Virtual Investor Summer Spotlight Series on Thursday, July 13, 2023 at 2:00 PM ET.

live video webcast of the presentation will be available in the Events section of the Resources page on the Company’s website ( A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  Pennsylvania Department of Aging Hosts Inaugural Volunteer Conference to Strengthen Aging Network